GTS Securities’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-5,063
Closed -$277K 1500
2025
Q3
$277K Buy
+5,063
New +$253K 0.01% 1079
2025
Q1
Sell
-6,398
Closed -$360K 1323
2024
Q4
$360K Sell
6,398
-9,028
-59% -$562K 0.02% 776
2024
Q3
$1.05M Sell
15,426
-3,095
-17% -$175K ﹤0.01% 2114
2024
Q2
$783K Sell
18,521
-67,115
-78% -$3.69M ﹤0.01% 2278
2024
Q1
$5.91M Sell
85,636
-3,252
-4% -$206K 0.01% 747
2023
Q4
$6.58M Buy
88,888
+57,892
+187% +$3.79M 0.01% 833
2023
Q3
$2.11M Buy
30,996
+27,004
+676% +$2.29M ﹤0.01% 1474
2023
Q2
$375K Buy
+3,992
New +$311K 0.01% 777

Other funds holding EXAS

GTS Securities's EXAS Position: Q4 2025 in Review

GTS Securities sold out of Exact Sciences (EXAS) in Q4 2025, closing a stake of 5,063 shares — an estimated $277K sold.

GTS Securities first reported a position in EXAS in Q2 2023 and held it in 8 quarters. The position peaked at $6.58M in Q4 2023. 711 funds tracked by Wall St. Rank hold EXAS as of Q4 2025.

  • GTS Securities reported no remaining Exact Sciences position as of Q4 2025 after selling out during the quarter.
  • GTS Securities sold 5,063 Exact Sciences shares in Q4 2025, an estimated $277K.
  • GTS Securities first reported a position in Exact Sciences in Q2 2023 and held it in 8 quarters.
  • GTS Securities's Exact Sciences position peaked at $6.58M in Q4 2023.
  • 711 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2025.

Based on GTS Securities's 13F filing for Q4 2025, filed 13 Feb 2026.